Limb-Girdle Muscular Dystrophy, Type 2D
·MeSH: Sarcoglycanopathies
Prevalence
5.0 / 100K
0 drugs in development·0 companies·0 clinical trials
Deep-dive into Limb-Girdle Muscular Dystrophy, Type 2D
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis